Abstract
Rationale
Acute physical dependence refers to the withdrawal syndrome precipitated by an opioid antagonist administered several hours after either a single dose or a short-term infusion of an opioid agonist.
Objectives
We examined the mechanism of nicotine-induced attenuation of naloxone-precipitated withdrawal syndrome when used to produce an aversive motivational state in a place-conditioning paradigm.
Methods
The effect of nicotine was investigated through place aversion induced by naloxone in morphine-pretreated rats. Additionally, the mechanism of nicotine action in this model was explored specifically in relation to the dopaminergic system through the use of dopamine receptor antagonist and agonist.
Results
Place avoidance behavior was potently elicited by naloxone (0.5 mg/kg s.c.) 24 h after a single exposure to morphine (10 mg/kg s.c.). Avoidance behavior was attenuated by pretreatment with a 0.2-mg/kg dose of nicotine 15 min prior to naloxone administration. The effect of nicotine was completely blocked by mecamylamine, but not hexamethonium. The dopamine receptor antagonists haloperidol (0.05, 0.1 mg/kg, s.c.), SCH23390 (0.1 mg/kg, s.c.), raclopride (1.0 mg/kg, s.c.) and eticlopride (0.1 mg/kg, s.c.) showed effects similar to mecamylamine. Additionally, the dopamine receptor agonist apomorphine (0.03, 0.1, 0.3 mg/kg, s.c.) inhibited naloxone-induced place aversion in morphine-treated rats.
Conclusion
The inhibitory effect of nicotine on place aversion induced by naloxone-precipitated morphine withdrawal may involve a dopaminergic portion of the central nervous system.
Similar content being viewed by others
References
Bickel WK, Stitzer ML, Liebson IA, Bigelow GE (1988) Acute physical dependence in man: effects of naloxone after brief morphine exposure. J Pharmacol Exp Ther 244:126–132
Clarke PS, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355–358
Clarke PS, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine receptors in the brain. Brain Res 323:390–395
Connelly MS, Littleton JM (1983) Lack of stereoselectivity in ability of nicotine to release dopamine from rat synaptosomal preparations. J Neurochem 41:1297–1302
Covington HE, Miczek KA (2003) Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress. Eur J Pharmacol 467:1–13
Eiserberg RM (1982) Further studies on the acute dependence produced by morphine in opiate naïve rats. Life Sci 31:1532–1540
Funada M, Shippenberg TS (1996) Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behav Pharmacol 7:448–453
Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA (1990) Acute opioid physical dependence in humans: effects of naloxone at 6 and 24 hours postmorphine. Pharmacol Biochem Behav 36:393–396
Higgins GA, Sellers EM (1994) Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav 48:1–8
Huidobro F (1971) Some relations between tolerance and physical dependence to morphine in mice. Eur J Pharmacol 15:79–84
Imperato A, Mulas A, Chiara GD (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337–338
Isola R, Vogelsberg V, Wemlinger TA, Neff NH, Hadjiconstantinou M (1999) Nicotine abstinence in the mouse. Brain Res 850:189–196
Jocob JJ, Michaud GM (1974) Acute physical dependence in the waking dog after a single low dose of morphine. Psychol Med 4:270–273
June HL, Stitzer ML, Cone EC (1995) Acute physical dependence: time course and relation to human plasma morphine concentrations. Clin Pharmacol Ther 57:270–280
Killen JD, Fortmann SP, Newman B, Varady A (1991) Prospective study of factors influencing the development of craving associated with smoking cessation. Psychopharmacology 105:191–196
Krystal JH, Redmond DE (1983) A preliminary description of acute physical dependence on morphine in the vervet monkey. Pharmacol Biochem Behav 18:289–291
Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779–784
Martin WR, Eades CG (1977) A comparison between acute and chronic physical dependence in the chronic spinal dog. J Pharmacol Exp Ther 146:385–394
McDonald RV, Parker LA, Siegel S (1997) Conditional sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. Pharmacol Biochem Behav 58:1–6
Mucha RF, Herz A (1985) Motivational properties of kappa and mu opiate receptor antagonists studied with place and taste preference conditioning. Psychopharmacology 86:274–280
Mucha RF, Iversen BD (1984) Reinforcing properties of morphine and naloxone revealed by conditional place preference: a procedural examination. Psychopharmacology 82:241–247
Mucha RF, Gritti MD, Kim C (1986) Aversion properties of opiate withdrawal in rats. NIDA Res Monogr 75:567–570
Parker LA, Joshi A (1998) Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine. Pharmacol Biochem Behav 61:331–333
Parker LA, Rennie M (1992) Naltrexone-induced aversions: assessment by place conditioning, taste reactivity and taste avoidance paradigms. Pharmacol Biochem Behav 41:559–565
Parker LA, Cyr JA, Santi AN, Burton PD (2002) The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine evaluation by taste and place aversion. Pharmacology Biochem Behav 72:87–92
Santi AN, Parker LA (2001) The dopamine antagonist, alpha-flupenthixol, interferes with naloxone-induced place aversion learning, but not with acute opiate dependence in rats. Pharmacol Biochem Behav 70:193–197
Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 27:11391–11398
Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50:35–39
Silagy C, Mant D, Fowler G, Lodge M (1994) Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343:130–142
Wei ET, Downs DA (1976) Physical dependence on opiate-like peptides. Science 193:1262–1263
Wily JN, Downs DA (1979) Naloxone-precipitated jumping in mice pretreated with acute injections of opioids. Life Sci 25:797–801
Zarrindast M-R, Farzin D (1996) Nicotine attenuates naloxone-induced jumping behavior in morphine-dependent mice. Eur J Pharmacol 298:1–6
Acknowledgements
This study was supported, in part, by a Grant-in-Aid for Drug Abuse Research from the Ministry of Health and Welfare, Japan, and by a grant from the Smoking Research Foundation of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Araki, H., Kawakami, Ky., Jin, C. et al. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Psychopharmacology 171, 398–404 (2004). https://doi.org/10.1007/s00213-003-1595-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1595-7